SCHEMBL106914

SCHEMBL106914

CCCC(=O)Cc1ccc(O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.54
CAMK2A Q9UQM7 1/20 0.54
HSD17B3 P37058 7/20 0.53
IAPP P10997 1/20 0.49
FNTA P49354 1/20 0.48
FNTB P49356 1/20 0.48
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CTBP2 P56545 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
ESR1 P03372 2/20 0.44
ADRA2A P08913 2/20 0.44
ADORA3 P0DMS8 2/20 0.44
TACR2 P21452 2/20 0.44
SLC6A2 P23975 2/20 0.44
SLC6A4 P31645 2/20 0.44
SLC6A3 Q01959 2/20 0.44
LMNA P02545 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2565115 0.88 HSD17B3 (0.56) CA2CAMK2AHSD17B3IAPPTRPV1
SCHEMBL4383629 0.86 HSD17B3 (0.58) CA2CAMK2AHSD17B3TRPV1ESR1
SCHEMBL27710521 0.86 HSD17B3 (0.44) CA2CAMK2AHSD17B3IAPPFNTA
SCHEMBL4541922 0.85 ALDH1A1 (0.48) CA2IAPPTDP1L3MBTL1LMNA
SCHEMBL8936320 0.85 HSD17B3 (0.59) CA2CAMK2AHSD17B3TRPV1ESR1
SCHEMBL9362946 0.85 HSD17B3 (0.59) CA2CAMK2AHSD17B3TRPV1ESR1
SCHEMBL9362853 0.85 HSD17B3 (0.59) CA2CAMK2AHSD17B3TRPV1ESR1
SCHEMBL1411319 0.83 L3MBTL1 (0.62) IAPPTDP1L3MBTL1CTBP2LMNA
SCHEMBL5548416 0.83 IAPP (0.44) HSD17B3IAPPTDP1L3MBTL1KDM4E
SCHEMBL43309 0.83 CA2 (0.58) CA2CAMK2AHSD17B3IAPPFNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116253626-B Alcohol ether compound and application thereof in water-based nano pesticide preparation 中国农业科学院农业环境与可持续发展研究所 2023-09-01 CN claimed
CN-116253626-A Alcohol ether compound and application thereof in water-based nano pesticide preparation 中国农业科学院农业环境与可持续发展研究所 2023-06-13 CN claimed
CN-115521249-A 2- [4- (1-oxoalkyl) phenoxy ] -3-picolinic acid, preparation method and application thereof 沈阳兴齐眼药股份有限公司 2022-12-27 CN claimed
EP-2463374-A2 Isolated alcohol dehydrogenase enzymes and uses thereof Bio Architecture Lab, Inc. (US) 2012-06-13 EP claimed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP claimed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US claimed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US claimed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
EP-3230463-B2 RAPID PRETREATMENT APALTA PATENTS OUE (EE) 2025-07-16 EP disclosed
CN-119978345-A Polyether modified amphiphilic carboxylic acid derivative and application thereof in nano pesticide 中国农业科学院农业环境与可持续发展研究所 2025-05-13 CN disclosed
CN-115521249-B 2- [4- (1-Oxo alkyl) phenoxy ] -3-picolinic acid, preparation method and application thereof 沈阳兴齐眼药股份有限公司 2025-03-11 CN disclosed
CN-115521251-B Pranoprofen intermediate compound, preparation method and application thereof 沈阳兴齐眼药股份有限公司 2024-12-27 CN disclosed
US-20240425893-A1 RAPID PRETREATMENT Apalta Patents OÜ (EE) 2024-12-26 US disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-05-04 US disclosed
EP-1555267-A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-07-20 EP disclosed
EP-0426804-B1 2-(2-HYDROXY-3-PHENOXYPROPYLAMINO)-ETHOXYBENZENE DERIVATIVES ICI PLC (GB) 1994-01-19 EP disclosed
EP-0426804-A1 2-(2-HYDROXY-3-PHENOXYPROPYLAMINO)-ETHOXYBENZENE DERIVATIVES. ICI PLC (GB) 1991-05-15 EP disclosed
WO-1990013535-A1 COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles NR2C2, NR4A3, NR4A2 CA2 1853/4885CAMK2A 2798/4885HSD17B3 111/4885
US-20090139134-A1 BIOFUEL PRODUCTION MGAM, DCXR, MANBA CA2 3146/4885CAMK2A 4018/4885HSD17B3 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.